McGreivy Jesse 4
4 · PHARMACYCLICS INC · Filed May 31, 2013
Insider Transaction Report
Form 4
McGreivy Jesse
VP, Clinical Science
Transactions
- Exercise/Conversion
Common Stock
2013-05-31$25.33/sh+9,479$240,103→ 9,479 total - Exercise/Conversion
Common Stock
2013-05-31$61.60/sh+5,000$308,000→ 14,479 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-05-31−9,479→ 25,521 totalExercise: $25.33From: 2012-04-16Exp: 2022-04-16→ Common Stock (9,479 underlying) - Sale
Common Stock
2013-05-31$91.13/sh−14,479$1,319,510→ 0 total - Exercise/Conversion
Stock Option (Right t Buy)
2013-05-31−5,000→ 35,000 totalExercise: $61.60From: 2013-04-11Exp: 2022-10-26→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on April 16, 2013 and 1/36th of the remaining shares will vest monthly thereafter.
- [F2]The option vests 6/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015 and April 11, 2016. The vesting of the options are subject to satisfaction of certain performance criteria.